Back to search

Article

SNAI2 cooperates with MEK1/2 and HDACs to suppress BIM- and BMF-dependent apoptosis in <i>TERT</i> promoter mutant cancers

2024-10-19

Abstract excerpt

Cancers with TERT promoter mutations (TPM) display elevated RAS pathway signaling and mesenchymal traits, and associate with lower patient survival rates. We examined whether RAS pathway signaling in TPM cancers cooperates with mesenchymal features to drive resistance to apoptosis. We observed that RAS pathway signaling in TPM cancers inhibited apoptosis by downregulating the pro-apoptotic protein BIM. By using i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e4589cf7-f3ed-5659-9d0e-bd2368a813ef
DOI
10.1101/2024.10.18.619052
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SNAI2 cooperates with MEK1/2 and HDACs to suppress BIM- and BMF-dependent apoptosis in <i>TERT</i> promoter mutant cancersDOI 10.1101/2024.10.18.619052
Select a neighboring publication to make it the new centre.